Interaction between enkephalinergic and dopaminergic systems in stressful situations

Akira Katoh, Toshitaka Nabeshima, Tsutomu Kameyama

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Mice exhibit a marked suppression of mobility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be a stress-induced response [D-Ala2,Met5]enkephalinamide (DAMEA, 40 and 80 nmol i.c.v.), a derivative resistant to [Met5]enkephalin-degrading enzyme activity, significantly attenuated the conditioned suppression of motility. The attenuation of conditioned suppression of motility induced by DAMEA was antagonized not only by naloxone (0.1 mg/kg s.c.), but also by 6-hydroxydopamine (6-OHDA, 100 μg/mouse, i.c.v.)-induced lessions of dopaminergic (DAergic) neurons. Pimozide (100 μg/kg i.p.) and a low dose of apomorphine (50 μg/kg s.c.) also inhibited the effect of DAMEA. In addition, DAMEA reversed the decrease in DA turnover in the striatum in the conditioned suppression group. These results suggest that the attenuation of conditioned suppression of motility induced by activation of the [Met5]enkephalinergic system may be related to the striatal DAergic system.

Original languageEnglish
Pages (from-to)95-99
Number of pages5
JournalEuropean Journal of Pharmacology
Volume193
Issue number1
DOIs
Publication statusPublished - 25-01-1991

Fingerprint

Oxidopamine
Pimozide
Corpus Striatum
Apomorphine
Dopaminergic Neurons
Naloxone
Shock
enkephalin degrading enzyme

All Science Journal Classification (ASJC) codes

  • Pharmacology

Cite this

@article{c8eaae6c7cea4554a3c9efa21c569615,
title = "Interaction between enkephalinergic and dopaminergic systems in stressful situations",
abstract = "Mice exhibit a marked suppression of mobility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be a stress-induced response [D-Ala2,Met5]enkephalinamide (DAMEA, 40 and 80 nmol i.c.v.), a derivative resistant to [Met5]enkephalin-degrading enzyme activity, significantly attenuated the conditioned suppression of motility. The attenuation of conditioned suppression of motility induced by DAMEA was antagonized not only by naloxone (0.1 mg/kg s.c.), but also by 6-hydroxydopamine (6-OHDA, 100 μg/mouse, i.c.v.)-induced lessions of dopaminergic (DAergic) neurons. Pimozide (100 μg/kg i.p.) and a low dose of apomorphine (50 μg/kg s.c.) also inhibited the effect of DAMEA. In addition, DAMEA reversed the decrease in DA turnover in the striatum in the conditioned suppression group. These results suggest that the attenuation of conditioned suppression of motility induced by activation of the [Met5]enkephalinergic system may be related to the striatal DAergic system.",
author = "Akira Katoh and Toshitaka Nabeshima and Tsutomu Kameyama",
year = "1991",
month = "1",
day = "25",
doi = "10.1016/0014-2999(91)90205-5",
language = "English",
volume = "193",
pages = "95--99",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

Interaction between enkephalinergic and dopaminergic systems in stressful situations. / Katoh, Akira; Nabeshima, Toshitaka; Kameyama, Tsutomu.

In: European Journal of Pharmacology, Vol. 193, No. 1, 25.01.1991, p. 95-99.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Interaction between enkephalinergic and dopaminergic systems in stressful situations

AU - Katoh, Akira

AU - Nabeshima, Toshitaka

AU - Kameyama, Tsutomu

PY - 1991/1/25

Y1 - 1991/1/25

N2 - Mice exhibit a marked suppression of mobility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be a stress-induced response [D-Ala2,Met5]enkephalinamide (DAMEA, 40 and 80 nmol i.c.v.), a derivative resistant to [Met5]enkephalin-degrading enzyme activity, significantly attenuated the conditioned suppression of motility. The attenuation of conditioned suppression of motility induced by DAMEA was antagonized not only by naloxone (0.1 mg/kg s.c.), but also by 6-hydroxydopamine (6-OHDA, 100 μg/mouse, i.c.v.)-induced lessions of dopaminergic (DAergic) neurons. Pimozide (100 μg/kg i.p.) and a low dose of apomorphine (50 μg/kg s.c.) also inhibited the effect of DAMEA. In addition, DAMEA reversed the decrease in DA turnover in the striatum in the conditioned suppression group. These results suggest that the attenuation of conditioned suppression of motility induced by activation of the [Met5]enkephalinergic system may be related to the striatal DAergic system.

AB - Mice exhibit a marked suppression of mobility when they are placed in the same cage in which they had previously received an electric shock. This suppression of motility is believed to be a stress-induced response [D-Ala2,Met5]enkephalinamide (DAMEA, 40 and 80 nmol i.c.v.), a derivative resistant to [Met5]enkephalin-degrading enzyme activity, significantly attenuated the conditioned suppression of motility. The attenuation of conditioned suppression of motility induced by DAMEA was antagonized not only by naloxone (0.1 mg/kg s.c.), but also by 6-hydroxydopamine (6-OHDA, 100 μg/mouse, i.c.v.)-induced lessions of dopaminergic (DAergic) neurons. Pimozide (100 μg/kg i.p.) and a low dose of apomorphine (50 μg/kg s.c.) also inhibited the effect of DAMEA. In addition, DAMEA reversed the decrease in DA turnover in the striatum in the conditioned suppression group. These results suggest that the attenuation of conditioned suppression of motility induced by activation of the [Met5]enkephalinergic system may be related to the striatal DAergic system.

UR - http://www.scopus.com/inward/record.url?scp=0026011053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026011053&partnerID=8YFLogxK

U2 - 10.1016/0014-2999(91)90205-5

DO - 10.1016/0014-2999(91)90205-5

M3 - Article

C2 - 1904821

AN - SCOPUS:0026011053

VL - 193

SP - 95

EP - 99

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -